Unlike other cancers [44], MPM does not appear to undergo frequent gain of function mutations in p110α (data not shown), however IHC analysis of archival MPM tumor samples revealed overexpression of p-AKT that supports the presence of highly active PI3K (Fig. 1A, B). This evidence concerns the gene AKT1 and neoplasm.